138 related articles for article (PubMed ID: 38366276)
1. Investigation of MHR-nephropathy relationship and the effect of SGLT2is on MHR in patients with type 2 diabetes.
Tekin BG; Pektaş E
Ir J Med Sci; 2024 Jun; 193(3):1283-1287. PubMed ID: 38366276
[TBL] [Abstract][Full Text] [Related]
2. Monocyte to high-density lipoprotein cholesterol ratio in patients with diabetes mellitus and diabetic nephropathy.
Karatas A; Turkmen E; Erdem E; Dugeroglu H; Kaya Y
Biomark Med; 2018 Sep; 12(9):953-959. PubMed ID: 30043636
[TBL] [Abstract][Full Text] [Related]
3. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
4. Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study.
Ishibashi F; Kosaka A; Tavakoli M
Front Endocrinol (Lausanne); 2022; 13():864332. PubMed ID: 35784562
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy.
Zhai Y; Cao X; Liu S; Shen Y
Ann Med; 2023; 55(2):2230446. PubMed ID: 37566692
[TBL] [Abstract][Full Text] [Related]
6. Effect of empagliflozin use on monocyte high-density lipoprotein ratio and plasma atherogenic index in obese and non-obese type 2 diabetic patients.
Sivgin H; Çetin S
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):8090-8100. PubMed ID: 37750637
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of effects of sodium-glucose co-transporter 2 inhibitor in Japanese type 2 diabetes mellitus patients with chronic kidney disease.
Kobayashi K; Toyoda M; Kimura M; Hatori N; Furuki T; Sakai H; Takihata M; Umezono T; Ito S; Suzuki D; Takeda H; Kanamori A; Degawa H; Yamamoto H; Machimura H; Mokubo A; Chin K; Obana M; Hishiki T; Aoyama K; Nakajima S; Umezawa S; Shimura H; Aoyama T; Sato K; Miyakawa M
Diab Vasc Dis Res; 2019 Jan; 16(1):103-107. PubMed ID: 30284913
[TBL] [Abstract][Full Text] [Related]
8. Association Between Monocyte-to-High-Density Lipoprotein (HDL) Cholesterol Ratio and Proteinuria in Patients With Type 2 Diabetes Mellitus: A Prospective Observational Study.
D Y; Sk SR; R NK; Pa A
Cureus; 2023 Sep; 15(9):e45783. PubMed ID: 37872916
[TBL] [Abstract][Full Text] [Related]
9. The relationship between monocyte to high-density lipoprotein cholesterol ratio and diabetic nephropathy.
Onalan E
Pak J Med Sci; 2019; 35(4):1081-1086. PubMed ID: 31372147
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of diabetic nephropathy patients without diabetic retinopathy: A retrospective observational study.
Li XQ; Zheng X; Chen M; Zhao MH
Medicine (Baltimore); 2017 May; 96(18):e6805. PubMed ID: 28471980
[TBL] [Abstract][Full Text] [Related]
11. Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson's disease.
Liu Z; Fan Q; Wu S; Wan Y; Lei Y
Lipids Health Dis; 2021 Apr; 20(1):35. PubMed ID: 33874966
[TBL] [Abstract][Full Text] [Related]
12. The association between monocyte HDL ratio and albuminuria in diabetic nephropathy.
Efe FK
Pak J Med Sci; 2021; 37(4):1128-1132. PubMed ID: 34290795
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil to lymphocyte and monocyte to high-density lipoprotein ratios are promising inflammatory indicators of bipolar disorder.
Kulacaoglu F; Yıldırım YE; Aslan M; İzci F
Nord J Psychiatry; 2023 Jan; 77(1):77-82. PubMed ID: 36074909
[TBL] [Abstract][Full Text] [Related]
14. The effects of Dapagliflozin on monocyte-HDL ratio and neutrophil-lymphocyte ratio among patients with type-2 diabetes mellitus.
Sen Uzeli Ü; Doğan M
Eur Rev Med Pharmacol Sci; 2023 Nov; 27(21):10577-10582. PubMed ID: 37975382
[TBL] [Abstract][Full Text] [Related]
15. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy.
Khan S; Qayyum S; Khan MNA
J Pak Med Assoc; 2024 May; 74(5):862-867. PubMed ID: 38783431
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-lymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy.
Huang W; Huang J; Liu Q; Lin F; He Z; Zeng Z; He L
Clin Endocrinol (Oxf); 2015 Feb; 82(2):229-33. PubMed ID: 25088518
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil to Lymphocyte Ratio (NLR) is a Better Tool Rather than Monocyte to High-Density Lipoprotein Ratio (MHR) and Platelet to Lymphocyte Ratio (PLR) in Central Retinal Artery Occlusions.
Guven S; Kilic D
Ocul Immunol Inflamm; 2021 Jul; 29(5):997-1001. PubMed ID: 32078399
[No Abstract] [Full Text] [Related]
18. Efficacy of Yishen Huashi Granules Combined with Linagliptin Tablets on Blood Glucose and Renal Function in Patients with Type 2 Diabetic Nephropathy.
Zhang P; Meng J; Duan M; Li D; Wang R
Comput Intell Neurosci; 2022; 2022():4272520. PubMed ID: 36177313
[TBL] [Abstract][Full Text] [Related]
19. Monocyte-to-high-density lipoprotein ratio and systemic immune-inflammation index: Potential parameters for the evaluation of disease activity and severity in Graves' ophthalmopathy?
Yılmaz Tuğan B; Ergen A; Özkan B
Int Ophthalmol; 2024 Mar; 44(1):154. PubMed ID: 38509387
[TBL] [Abstract][Full Text] [Related]
20. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
